Publications by authors named "Jennifer Bos"

Claim this Profile
O
Osmotic gradient ektacytometry - a novel diagnostic approach for neuroacanthocytosis syndromes.
Carolina A Hernández, Kevin Peikert, Min Qiao, Alexis Darras, Jonathan R A de Wilde, Jennifer Bos

Front Neurosci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease.
Myrthe J van Dijk, Titine J J Ruiter, Sigrid van der Veen, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos

Hemasphere· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.
Maite E Houwing, Jennifer Bos, Richard van Wijk, Eduard J van Beers, Marjon H Cnossen

Int J Lab Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omega-3 supplementation changes the physical properties of leukocytes but not erythrocytes in healthy individuals: An exploratory trial.
Jan Philipp Schuchardt, Martin Kräter, Maximilian Schlögel, Jochen Guck, Brigitte A van Oirschot-Hermans, Jennifer Bos

Prostaglandins Leukot Essent Fatty Acids· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease.
Myrthe J van Dijk, Marissa J M Traets, Brigitte A van Oirschot, Titine J J Ruiter, Jonathan R A de Wilde, Jennifer Bos

EJHaem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease.
Minke A E Rab, Celeste K Kanne, Camille Boisson, Jennifer Bos, Brigitte A van Oirschot

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia.
Myrthe J van Dijk, Brigitte A van Oirschot, Alexander N Harrison, Steffen M Recktenwald, Min Qiao, Jennifer Bos

Am J Hematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.
Myrthe J van Dijk, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Cleo Derichs

Blood Adv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study.
Myrthe J van Dijk, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Cleo Derichs

Am J Hematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy.
Minke A E Rab, Jennifer Bos, Brigitte A van Oirschot, Stephanie van Straaten, Penelope A Kosinski

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease.
Camille Boisson, Minke A E Rab, Elie Nader, Céline Renoux, Celeste Kanne, Jennifer Bos

Cells· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease.
Minke A E Rab, Celeste K Kanne, Jennifer Bos, Brigitte A van Oirschot, Camille Boisson

Am J Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization.
Minke A E Rab, Celeste K Kanne, Jennifer Bos, Camille Boisson, Brigitte A van Oirschot

Am J Hematol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Celeste K Kanne, Vivien A Sheehan

J Vis Exp· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Tesy H Merkx, Annet C W van Wesel

Am J Hematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis